Results 91 to 100 of about 238,371 (341)

Correlates and Prognostic Value of Serial N‐Terminal Pro‐B‐Type Natriuretic Peptide Assay in Congenitally Corrected Transposition of the Great Arteries

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular biomarkers such as NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) are used for heart failure risk stratification in patients with acquired heart disease, but there are limited data about its role in patients with ...
Ahmed Bahnasy, Meena Bai, Sara Aboelmaaty, Mohamed Ellabbad, William R. Miranda, Heidi M. Connolly, Allan S. Jaffe, Alexander C. Egbe   +7 more
doaj   +1 more source

Levels of NT‑proBNP in patients with cancer

Oncology Letters, 2023
At present, it is well known that natriuretic peptides may be produced by cancer cells. Stimulation of N-terminal pro B-type natriuretic peptide (NT-proBNP) synthesis may be a reaction to activity of several proinflammatory cytokines. NT-proBNP is also a marker of myocardial damage during cardiotoxic chemotherapy by anthracyclines.
Jozef, Chovanec, Jozef, Chovanec, Michal, Chovanec, Michal, Mego   +3 more
openaire   +2 more sources

Relation of Kidney Function Decline and NT-proBNP with Risk of Mortality and Readmission in Acute Decompensated Heart Failure.

American Journal of Medicine, 2020
BACKGROUND Acute declines in kidney function occur in approximately 20-30% of patients with acute decompensated heart failure, but its significance is unclear and importance of its context is not known.
Wendy McCallum, H. Tighiouart, M. Kiernan, G. Huggins, M. Sarnak   +4 more
semanticscholar   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai, Minoru Yasukawa, Shigeru Shibata   +2 more
wiley   +1 more source

Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.

Journal of the American College of Cardiology, 2019
BACKGROUND Clinicians need improved tools to better identify nonacute heart failure with preserved ejection fraction (HFpEF). OBJECTIVES The purpose of this study was to derive and validate circulating microRNA signatures for nonacute heart failure (HF)
L. L. Wong, R. Zou, Lihan Zhou, Jia Yuen Lim, Dominic C. Y. Phua, Chengcheng Liu, J. C. Chong, J. Y. X. Ng, O. Liew, S. Chan, Yei-Tsung Chen, Michelle M. Y. Chan, Poh Shuan Daniel Yeo, T. Ng, L. Ling, D. Sim, K. Leong, H. Ong, F. Jaufeerally, R. Wong, P. Chai, A. Low, M. Lund, G. Devlin, R. Troughton, V. Cameron, R. Doughty, C. Lam, H. Too, A. Richards   +29 more
semanticscholar   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease

International Journal of Cardiology: Heart & Vasculature
Background: Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension.
Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg   +5 more
doaj   +1 more source

Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome

Cardiology Research and Practice, 2019
Background. The diagnostic and prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure is well established. However, additional factors may influence its concentration.
Paweł Krzesiński, Wiesław Piechota, Katarzyna Piotrowicz, Grzegorz Gielerak, Agnieszka Woźniak-Kosek   +4 more
doaj   +1 more source

Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients. results from the BACH Study (Biomarkers in ACute Heart Failure) [PDF]

, 2013
Objectives: The purpose of this study was to assess the impact of atrial fibrillation (AF) on the performance of mid-region amino terminal pro-atrial natriuretic peptide (MR-proANP) in comparison with the B-type peptides (BNP and NT-proBNP) for diagnosis
Anand I, Anker SD, Christenson R, Clopton P, Daniels LB, DI SOMMA, Salvatore, Filippatos GS, Hartmann O, Hogan C, Maisel A., Mockel M, Mueller C, Neath SX, Ng L, Nowak R, Peacock WF, Ponikowski P, Richards M, Shah K, Wu AH   +19 more
core   +1 more source

NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.

JACC. Heart failure, 2020
OBJECTIVES This study examined the effects of sacubitril/valsartan on N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and determined patient characteristics associated with favorable NT-proBNP reduction response.
D. Pascual-Figal, R. Wachter, M. Senni, W. Bao, A. Noè, H. Schwende, D. Butylin, M. Prescott   +7 more
semanticscholar   +1 more source